AB&B Bio-Tech auditor Deloitte resigns, citing concerns over HK$272 million fund investments

Reuters04-14 08:12

AB&B Bio-Tech auditor Deloitte resigns, citing concerns over HK$272 million fund investments

AB&B Bio-Tech auditor Deloitte Touche Tohmatsu resigned with immediate effect on April 13, 2026 during audit of fiscal 2025 results.
Deloitte flagged HKD 272 million of fund subscriptions made shortly after August 2025 IPO, followed by redemptions on Dec. 30, 2025 with low return.
Deloitte also raised concerns over consultancy payments of about HKD 36 million before year-end, plus about HKD 22 million after year-end, involving consultants linked to entities tied to fund investments.
Auditor urged an independent forensic investigation, citing concerns over commercial substance of transactions.
Shares remain suspended from April 1, 2026 while company seeks shareholder approval to appoint a new auditor to complete fiscal 2025 audit.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AB&B Bio-Tech Co. Ltd. JS published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260414-12104381), on April 14, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2627462859?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-14 08:12","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2627462859","market":"us","top_or_hot":-1,"title":"AB&B Bio-Tech auditor Deloitte resigns, citing concerns over HK$272 million fund investments","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      AB&amp;B Bio-Tech auditor Deloitte resigns, citing concerns over HK$272 million fund investments\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<ul>\n<li>\n          AB&amp;B Bio-Tech auditor Deloitte Touche Tohmatsu resigned with immediate effect on April 13, 2026 during audit of fiscal 2025 results.\n        </li>\n<li>\n          Deloitte flagged HKD 272 million of fund subscriptions made shortly after August 2025 IPO, followed by redemptions on Dec. 30, 2025 with low return.\n        </li>\n<li>\n          Deloitte also raised concerns over consultancy payments of about HKD 36 million before year-end, plus about HKD 22 million after year-end, involving consultants linked to entities tied to fund investments.\n        </li>\n<li>\n          Auditor urged an independent forensic investigation, citing concerns over commercial substance of transactions.\n        </li>\n<li>\n          Shares remain suspended from April 1, 2026 while company seeks shareholder approval to appoint a new auditor to complete fiscal 2025 audit.\n        </li>\n</ul>\n<br/>\n<br/>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AB&amp;B Bio-Tech Co. Ltd. JS published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260414-12104381), on April 14, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AB&B Bio-Tech auditor Deloitte resigns, citing concerns over HK$272 million fund investments</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAB&B Bio-Tech auditor Deloitte resigns, citing concerns over HK$272 million fund investments\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-04-14 08:12</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      AB&amp;B Bio-Tech auditor Deloitte resigns, citing concerns over HK$272 million fund investments\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<ul>\n<li>\n          AB&amp;B Bio-Tech auditor Deloitte Touche Tohmatsu resigned with immediate effect on April 13, 2026 during audit of fiscal 2025 results.\n        </li>\n<li>\n          Deloitte flagged HKD 272 million of fund subscriptions made shortly after August 2025 IPO, followed by redemptions on Dec. 30, 2025 with low return.\n        </li>\n<li>\n          Deloitte also raised concerns over consultancy payments of about HKD 36 million before year-end, plus about HKD 22 million after year-end, involving consultants linked to entities tied to fund investments.\n        </li>\n<li>\n          Auditor urged an independent forensic investigation, citing concerns over commercial substance of transactions.\n        </li>\n<li>\n          Shares remain suspended from April 1, 2026 while company seeks shareholder approval to appoint a new auditor to complete fiscal 2025 audit.\n        </li>\n</ul>\n<br/>\n<br/>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AB&amp;B Bio-Tech Co. Ltd. JS published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260414-12104381), on April 14, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02627","symbol_name":"中慧生物-B","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260414:nNDL4QY3gv:1","article_id":"2627462859","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2627462859","pubTimestamp":1776125532,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"AB&B Bio-Tech auditor Deloitte Touche Tohmatsu resigned with immediate effect on April 13, 2026 during audit of fiscal 2025 results.Deloitte flagged HKD 272 million of fund subscriptions made shortly after August 2025 IPO, followed by redemptions on Dec. 30, 2025 with low return.Deloitte also raised concerns over consultancy payments of about HKD 36 million before year-end, plus about HKD 22 million after year-end, involving consultants linked to entities tied to fund investments.Auditor urged an independent forensic investigation, citing concerns over commercial substance of transactions.Shares remain suspended from April 1, 2026 while company seeks shareholder approval to appoint a new auditor to complete fiscal 2025 audit.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as fi","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02627":"中慧生物-B","BK1161":"生物科技"},"translate_title":"AB&B生物科技审计师德勤辞职，理由是对2.72亿港元基金投资感到担忧","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02627":0.9},"content_text":"AB&B Bio-Tech auditor Deloitte resigns, citing concerns over HK$272 million fund investments\n    \n\n\n          AB&B Bio-Tech auditor Deloitte Touche Tohmatsu resigned with immediate effect on April 13, 2026 during audit of fiscal 2025 results.\n        \n\n          Deloitte flagged HKD 272 million of fund subscriptions made shortly after August 2025 IPO, followed by redemptions on Dec. 30, 2025 with low return.\n        \n\n          Deloitte also raised concerns over consultancy payments of about HKD 36 million before year-end, plus about HKD 22 million after year-end, involving consultants linked to entities tied to fund investments.\n        \n\n          Auditor urged an independent forensic investigation, citing concerns over commercial substance of transactions.\n        \n\n          Shares remain suspended from April 1, 2026 while company seeks shareholder approval to appoint a new auditor to complete fiscal 2025 audit.\n        \n\n\n\n\n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AB&B Bio-Tech Co. Ltd. JS published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260414-12104381), on April 14, 2026, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"event","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":true,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2627462859","isCrawlerRequest":true}